C
넥스트바이오메디컬
389650KOSDAQ45.5 / 100
Reference Date: 2026-10-23
Financial Score18.0 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 10.2% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
NextBioMedical is a biopharma company specializing in drug delivery systems, biocompatible medical devices, and oncology treatments. It focuses on developing pharmaceutical-medical device convergence products, particularly drug-eluting beads for liver cancer therapy and interventional radiology technologies.
Number of Employees
81people
Average Salary
45.6M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
4.53Industry Average 1.200.0Point
3.8x industry avg (risky)
ROE
-0.67Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
6.47Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2024~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲72.7% (1-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲79.9% (1-year basis)
ROE Trend
0.0 / 4
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (1%, downtrend)
Current 26,350Won52-week high 98,00052-week low 25,050
1-month return1.0Point
1m -10.22% (falling)
Volume trend3.0Point
Volume flat
Detailed Disclosure
0 totalPositive 0Neutral 0Negative 0